Skip to main content

ERRATUM article

Front. Nutr., 07 December 2022
Sec. Clinical Nutrition
Volume 9 - 2022 | https://doi.org/10.3389/fnut.2022.1091846
This article is part of the Research Topic Impact of Environment, Physical Activity, Nutrition and Mental Health in Pediatric Rheumatology Diseases: Towards an Integrative Approach in Patient Management View all 5 articles

Erratum: Impact of fibre and red/processed meat intake on treatment outcomes among patients with chronic inflammatory diseases initiating biological therapy: A prospective cohort study

This article is an erratum on:

  1. Impact of fibre and red/processed meat intake on treatment outcomes among patients with chronic inflammatory diseases initiating biological therapy: A prospective cohort study

    1. Read original article
\nFrontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Impact of fibre and red/processed meat intake on treatment outcomes among patients with chronic inflammatory diseases initiating biological therapy: A prospective cohort study

by Overgaard, S. H., Sørensen, S. B., Munk, H. L., Nexøe, A. B., Glerup, H., Henriksen, R. H., Guldmann, T., Pedersen, N., Saboori, S., Hvid, L., Dahlerup, J. F., Hvas, C. L., Jawhara, M., Andersen, K. W., Pedersen, A. K., Nielsen, O. H., Bergenheim, F., Brodersen, J. B., Heitmann, B. L., Halldorsson, T. I., Holmskov, U., Bygum, A., Christensen, R., Kjeldsen, J., Ellingsen, T., and Andersen, V. (2022). Front. Nutr. 9:985732. doi: 10.3389/fnut.2022.985732

Due to a production error, there was a mistake in the legend for Figure 1 as published. The legend for Figure 2 was incorrectly used in its place. The correct legend appears below.

Flow chart of the enrolment of participants. Number of Chronic Inflammatory Disease patients who were screened, included in the study and included in the analysis. Patients screened for eligibility were not explicitly recorded in the study. For CD, UC, and PsO we estimated a number based on the mean inclusion rate from two clinics that kept a pre-screening log. For RA, axSpA, and PsA, the number is not an estimate but the total number of patients that initiated biologic treatment in the clinic during enrolment. IBD, Inflammatory bowel disease (Crohn's disease and Ulcerative colitis); CD, Crohn's disease; UC, Ulcerative colitis; RA, Rheumatoid arthritis; axSpA, Axial spondyloarthritis; PsA, Psoriatic arthritis; PsO, Psoriasis; FFQ, Food Frequency Questionnaire; HFLM, high fibre/low meat; LFHM, low fibre/high meat; ITT, intention-to-treat; SF-12 PCS + MCS, short form health survey the physical and mental component summary, The short health scale includes four health dimensions (symptom burden, functional status, disease-related burden and general wellbeing); CRP, C-reactive protein.

Due to a production error, there was a mistake in the legend for Figure 2 as published. The legend for Figure 1 was incorrectly used in its place. The correct legend appears below.

Meta-analysis (random effects model) of the included Chronic Inflammatory Diseases (CIDs) on the “As Observed” population comparing clinical response to biologics in patients with a high intake of fibre and low intake of red/processed meat (HFLM) vs. patients with a low intake of fibre and high intake of red/processed meat (LFHM). The horizontal lines represent the odds ratio (OR) ± 95% confidence interval. Event = clinical response according to the specified criteria for each CID, i.e., the number shows how many out of the total number of participants in the group, that have had a clinical response. The “As Observed” populations means patients with complete data for clinical response (i.e., 17 patients are excluded).

The publisher apologizes for this mistake. The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: chronic inflammatory disease, biologic therapy, diet, red meat, fibre, processed meat, rheumatoid arthritis, inflammatory bowel disease

Citation: Frontiers Production Office (2022) Erratum: Impact of fibre and red/processed meat intake on treatment outcomes among patients with chronic inflammatory diseases initiating biological therapy: A prospective cohort study. Front. Nutr. 9:1091846. doi: 10.3389/fnut.2022.1091846

Received: 07 November 2022; Accepted: 07 November 2022;
Published: 07 December 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2UmI3gwMDA0MDtmcm9udGllcnNpbi5vcmc=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.